Regenerating gene I regulates interleukin-6 production in squamous esophageal cancer cells

Biochemical and Biophysical Research Communications

Volumn 392, Issue 1, 2010, Pages 4-8

  Usami, Shuetsu ^a   Motoyama, Satoru ^a   Koyota, Souichi ^a   Wang, Jingshu ^a   Hayashi Shibuya, Kaori ^a   Maruyama, Kiyotomi ^a   Takahashi, Naoko ^a   Saito, Hajime ^a   Minamiya, Yoshihiro ^a   Takasawa, Shin ^b   Ogawa, Jun ichi ^a   Sugiyama, Toshihiro ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytokine; Esophageal cancer; Interleukin 6; REG I

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LECTIN; REGENERATING GENE IALPHA PROTEIN; REGENERATING GENE IBETA PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESOPHAGUS CANCER; GENE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REG I GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; HUMANS; INTERLEUKIN-6; LITHOSTATHINE; NEOPLASMS, SQUAMOUS CELL; TRANSFECTION;

EID: 74849112325     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.129     Document Type: Article

References (42)

1. Terazono K., Yamamoto H., Takasawa S., et al. A novel gene activated in regenerating islets. J. Biol. Chem. 263 (1988) 2111-2114
2. Moriizumi S., Watanabe T., Unno M., et al. Isolation, structural determination and expression of a novel reg gene, human regI beta. Biochim. Biophys. Acta 1217 (1994) 199-202
3. Unno M., Itoh T., Watanabe T., et al. Islet beta-cell regeneration and reg genes. Adv. Exp. Med. Biol. 321 (1992) 61-69
4. Miyaoka Y., Kadowaki Y., Ishihara S., et al. Transgenic overexpression of Reg protein caused gastric cell proliferation and differentiation along parietal cell and chief cell lineages. Oncogene 23 (2004) 3572-3579
5. Yonemura Y., Sakurai S., Yamamoto H., et al. REG gene expression is associated with the infiltrating growth of gastric carcinoma. Cancer 98 (2003) 1394-1400
6. Fukui H., Fujii S., Takeda J., et al. Expression of reg1 alpha protein in human gastric cancers. Digestion 69 (2004) 177-184
7. Ose T., Kadowaki Y., Fukuhara H., et al. Reg 1-knockout mice reveal its role in regulation of cell growth that is required in generation and maintenance of the villous structure of small intestine. Oncogene 26 (2007) 349-359
8. Shinozaki S., Nakamura T., Imura M., et al. Upregulation of REG1α and GW112 in the epithelium of inflamed colonic mucosa. Gut 48 (2001) 623-629
9. Bernard-Perrone F.R., Renaud W.P., Guy-Crotte O.M., et al. Expression of REG protein during cell growth and differentiation of two human colon carcinoma cell lines. J. Histochem. Cytochem. 47 (1999) 863-870
10. Rechreche H., Montalto G., Mallo G.V., et al. Pap, reg Iα and reg Iβ mRNAs are concomitantly up-regulated during human colorectal carcinogenesis. Int. J. Cancer 81 (1999) 688-694
11. Dhar D.K., Udagawa J., Ishihara S., et al. Expression of regenerating gene I in gastric adenocarcinomas: correlation with tumor differentiation status and patient survival. Cancer 100 (2004) 1130-1136
12. Hayashi K., Motoyama S., Koyota S., et al. REG I enhances chemo- and radiosensitivity in squamous cell esophageal cancer cells. Cancer Sci. 99 (2008) 2491-2495
13. Motoyama S., Sugiyama T., Ueno Y., et al. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patient treated with neoadjuvant chemoradiotherapy followed by esophagectomy. Ann. Surg. Oncol. 13 (2006) 1724-1731
14. Hayashi K., Motoyama S., Sugiyama T., et al. REG Iα is a reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients. Ann. Surg. Oncol. 15 (2008) 1224-1231
15. Mocellin S., Wang E., and Marincola F.M. Cytokines and immune response in the tumor microenvironment. J. Immunother. 24 (2001) 392-407
16. Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci. 97 (2006) 439-447
17. Kishimoto T. Interleukin-6: from basic science to medicine - 40 years in immunology. Annu. Rev. Immunol. 23 (2005) 1-21
18. Oka M., Hirose K., Iizuka N., et al. Cytokine mRNA expression patterns in human esophageal cancer cell lines. J. Interferon Cytokine Res. 15 (1995) 1005-1009
19. Eustace D., Han X., Gooding R., et al. Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro. Gynecol. Oncol. 50 (1993) 151-159
20. Imada K., and Leonard W. The Jak-STAT pathway. Mol. Immunol. 37 (2000) 1-11
21. Jones S.A., Horiuchi S., Topley N., et al. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 15 (2001) 43-58
22. Hong D.S., Angelo L.S., and Kurzrock R. Interleukin-6 and its receptor in cancer. Cancer 110 (2007) 1911-1928
23. Heikkila K., Ebrahim S., and Lawlor D.A. Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur. J. Cancer 44 (2008) 937-945
24. Hirano T., Ishihara K., and Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19 (2000) 2548-2556
25. Hodge D.R., Hurt E.M., and Farrar W.L. The role of IL-6 and STAT3 in inflammation and cancer. Eur. J. Cancer 41 (2005) 2502-2512
26. Sansone P., Storci G., Tavolari S., et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J. Clin. Invest. 117 (2007) 3988-4002
27. Gao S.P., Mark K.G., Leslie K., et al. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J. Clin. Invest. 117 (2007) 3846-3856
28. Mariette C., Piessen G., and Triboulet J.P. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol. 8 (2007) 545-553
29. Kleinberg L., and Forastiere R.A. Chemoradiation in the management of esophageal cancer. J. Clin. Oncol. 25 (2007) 4110-4117
30. Hong A., Zhang M., Leigh B., et al. Induction of interleukin-6 and oncostatin M by radiation in Kaposi's sarcoma cell lines. Int. J. Radiat. Oncol. Biol. Phys. 50 (2001) 533-540
31. Usuda J., Okunaka T., Furukawa K., et al. Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis. Int. J. Cancer 93 (2001) 475-480
32. Cecic I., and Korbelik M. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett. 183 (2002) 43-51
33. Du H., Bay B.H., Mahendran R., et al. Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer. Cancer Lett. 235 (2006) 202-208
34. Schutter H.D., Landuyt W., Verbeken E., et al. The prognostic value of the hypoxia markers CA IX and GLUT I and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy ± chemotherapy. BMC Cancer 5 (2005) 42
35. Nishino H., Miyata M., and Kitamura K. The effect of interleukin-6 on enhancing the invasiveness of head and neck cancer cells in vitro. Eur. Arch. Otorhinolaryngol. 255 (1998) 468-472
36. Tamatani T., Azuma M., Ashida Y., et al. Enhanced radiosensitization and chemosensitization in NF-κB-suppressed human oral cancer cells via the inhibition of γ-irradiation- and 5-FU-induced production of IL-6 and IL-8. Int. J. Cancer 108 (2004) 912-921
37. Tamatani T., Azuma M., Motegi K., et al. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-κB activity in human oral squamous cell carcinoma cells. Int. J. Oncol. 31 (2007) 761-768
38. Leu C.M., Wong F.H., Chang C., et al. Interleukin-6 acts an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways. Oncogene 22 (2003) 7809-7818
39. Efimova E.V., Liang H., Pitroda S.P., et al. Radioresistance of Stat1 over-expressing tumor cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling. Int. J. Radiat. Biol. 85 (2009) 421-431
40. Okamoto H., and Takasawa S. Recent advances in the Okamoto model; the CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in β-cells. Diabetes 51 (2002) 462-473
41. Sekikawa A., Fukui H., Fujii S., et al. REG Iα protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer. Gastroenterology 128 (2005) 642-653
42. Akiyama T., Takasawa S., Nata K., et al. Activation of Reg gene, a gene for insulin-producing β-cell regeneration: poly(ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly(ADP-ribosyl)ation. Proc. Natl. Acad. Sci. USA 98 (2001) 48-53